Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Sullivan

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Addiction (Abingdon, England)|July 18, 2019
Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanismEdward V Nunes, Adam Bisaga, Evgeny Krupitsky, et al.
The Journal of Pain|October 27, 2009
Sex differences and hormonal influences on response to mechanical pressure pain in humansWilliam J Kowalczyk, Maria A Sullivan, Suzette M Evans, et al.
Physiology & Behavior|October 13, 2015
The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid usersJermaine D Jones, Maria A Sullivan, Jeanne M Manubay, et al.
Journal of Substance Abuse Treatment|December 24, 2002
Behavioral naltrexone therapy: an integrated treatment for opiate dependenceJami L Rothenberg, Maria A Sullivan, Sarah H Church, et al.
The American Journal on Addictions|April 12, 2011
A pilot study of neurocognitive function in older and younger cocaine abusers and controlsRaj K Kalapatapu, Nehal P Vadhan, Eric Rubin, et al.
Drug and Alcohol Dependence|July 6, 2013
Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?Maria A Sullivan, Adam Bisaga, John J Mariani, et al.
The American Journal on Addictions|June 8, 2025
Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Addiction Biology|July 26, 2014
Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin usersJermaine D Jones, Maria A Sullivan, Suzanne K Vosburg, et al.
Drug and Alcohol Dependence|February 8, 2022
Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
BMC Psychiatry|April 2, 2024
Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorderBrittany D Roy, Jianheng Li, Cathy Lally, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Addiction (Abingdon, England)|July 18, 2019
Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanismEdward V Nunes, Adam Bisaga, Evgeny Krupitsky, et al.
The Journal of Pain|October 27, 2009
Sex differences and hormonal influences on response to mechanical pressure pain in humansWilliam J Kowalczyk, Maria A Sullivan, Suzette M Evans, et al.
Physiology & Behavior|October 13, 2015
The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid usersJermaine D Jones, Maria A Sullivan, Jeanne M Manubay, et al.
Journal of Substance Abuse Treatment|December 24, 2002
Behavioral naltrexone therapy: an integrated treatment for opiate dependenceJami L Rothenberg, Maria A Sullivan, Sarah H Church, et al.
The American Journal on Addictions|April 12, 2011
A pilot study of neurocognitive function in older and younger cocaine abusers and controlsRaj K Kalapatapu, Nehal P Vadhan, Eric Rubin, et al.
Drug and Alcohol Dependence|July 6, 2013
Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?Maria A Sullivan, Adam Bisaga, John J Mariani, et al.
The American Journal on Addictions|June 8, 2025
Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Addiction Biology|July 26, 2014
Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin usersJermaine D Jones, Maria A Sullivan, Suzanne K Vosburg, et al.
Drug and Alcohol Dependence|February 8, 2022
Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
BMC Psychiatry|April 2, 2024
Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorderBrittany D Roy, Jianheng Li, Cathy Lally, et al.
Pageof 9